Tag: Healthcare regulations
Telehealth Rules for Adderall, Buprenorphine, and Controlled Meds: DEA Guidelines
DEA Introduces New Telehealth Rules for Controlled SubstancesThe Drug Enforcement Administration (DEA) has finally unveiled a long-awaited announcement regarding the prescription of controlled substances...
Former Hahn Adviser Joins Trump’s FDA Transition Team with Top Capitol Hill Aide
Former Hahn Adviser Joins Trump's FDA Transition Team with Top Capitol Hill AideIn a strategic move signaling the early efforts of President-elect Trump's team...
South African Regulator’s Decision on Vertex CF Drugs Access Angers Activists
South African Regulator's Decision on Vertex CF Drugs Access Angers ActivistsAfter a thorough investigation, South African regulators have concluded that Vertex Pharmaceuticals has met...
U.K. Restricts Lilly’s Obesity Drug, Pharma Layoffs, and More: Pharmalittle Update
U.K. Restricts Lilly's Obesity Drug to Those in Greatest NeedIn a move to adapt to the rising demand for obesity treatment, the U.K. announced...
U.K. Tightens Restrictions on Eli Lilly’s Obesity Drug for High-Need Patients
U.K. to Restrict Eli Lilly's Obesity Drug for High-Need PatientsLONDON - In a bid to address the rising demand for obesity treatment, the U.K....
Target: Novo targeting compounded obesity drugs and Amgen ‘at risk’ launchNew Title: Novo Targets...
Hello, everyone! It's great to be here with you today. We hope you're all doing well and ready to dive into some interesting news....
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
